Zacks.com on MSN4d
GSK Gets EC Nod for Liquid Version of Meningococcal Vaccine Menveo
GSK plc GSK announced that the European Commission (EC) has approved a single-vial, fully liquid presentation of its ...
PMLiVE3d
GSK granted EC approval for meningococcal disease vaccine Menveo
GSK’s fully liquid presentation of its meningococcal vaccine Menveo has been approved by the European Commission (EC) to ...
The Pharma Letter5d
EC nod for GSK’s Menveo meningococcal vaccine
The European Commission (EC) has approved a single-vial, fully liquid presentation of Menveo (meningococcal Group A, C, W-135 ...
Daily3d
GSK fully liquid Menveo meningococcal vaccine approved by European Commission
London: GSK plc has announced that the European Commission (EC) has approved a single-vial, fully liquid presentation of ...
GlobalData on MSN4d
EC approves GSK’s Menveo vaccine presentation for IMD
The EC has granted approval for presentation of GSK's Menveo vaccine (MenACWY) for invasive meningococcal disease (IMD).
Nasdaq5d
GSK announces EC approved single-vial presentation of Menveo
GSK (GSK) announced that the European Commission, EC, has approved a single-vial, fully liquid presentation of Menveo to help protect against invasive meningococcal disease, IMD, caused by ...
London South East5d
GSK liquid meningitis vaccine authorised in EU
GSK plc (LSE/NYSE: GSK) today announced that the European Commission (EC) has approved a single-vial, fully liquid presentation of Menveo (Meningococcal Group A, C, W-135 and Y conjugate vaccine ...